Total Payments
$5,148
2024 Payments
$1,087
Companies
52
Transactions
204
Medicare Patients
130
Medicare Billing
$8,559
Payment Breakdown by Category
Food & Beverage$4,307 (83.7%)
Other$681.53 (13.2%)
Education$159.53 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,307 | 195 | 83.7% |
| Long term medical supply or device loan | $681.53 | 7 | 13.2% |
| Education | $159.53 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,026 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $335.93 | 16 | $0 (2023) |
| Seagen Inc. | $305.36 | 12 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $246.70 | 6 | $0 (2024) |
| ABBVIE INC. | $236.75 | 11 | $0 (2024) |
| Daiichi Sankyo Inc. | $197.06 | 10 | $0 (2023) |
| Celgene Corporation | $144.61 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $143.48 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $139.71 | 6 | $0 (2024) |
| Stemline Therapeutics Inc. | $122.74 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,087 | 24 | Novartis Pharmaceuticals Corporation ($746.56) |
| 2023 | $2,612 | 122 | Novartis Pharmaceuticals Corporation ($230.52) |
| 2022 | $1,435 | 57 | Seagen Inc. ($187.16) |
| 2021 | $15.57 | 1 | Janssen Pharmaceuticals, Inc ($15.57) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Oncology | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 07/05/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 05/11/2024 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: GENERAL SURGERY | ||||||
| 05/02/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 04/16/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Oncology | ||||||
| 03/29/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Oncology | ||||||
| 03/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 03/01/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: ONCOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 01/26/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Hematology/Oncology | ||||||
| 01/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 16 | 16 | $14,960 | $1,078 |
| 2021 | 2 | 59 | 59 | $46,755 | $3,847 |
| 2020 | 2 | 55 | 55 | $45,057 | $3,634 |
Total Patients
130
Total Services
130
Medicare Billing
$8,559
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 16 | 16 | $14,960 | $1,078 | 7.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 30 | 30 | $28,050 | $2,518 | 9.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 29 | 29 | $18,705 | $1,328 | 7.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 30 | 30 | $28,698 | $2,519 | 8.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 25 | 25 | $16,359 | $1,115 | 6.8% |
About Rebecca Daniels, NP
Rebecca Daniels, NP is a Family healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1265957278.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rebecca Daniels, NP has received a total of $5,148 in payments from pharmaceutical and medical device companies, with $1,087 received in 2024. These payments were reported across 204 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($4,307).
As a Medicare-enrolled provider, Daniels has provided services to 130 Medicare beneficiaries, totaling 130 services with total Medicare billing of $8,559. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Athens, GA
- Active Since 08/10/2017
- Last Updated 01/15/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1265957278
Products in Payments
- KISQALI (Drug) $802.88
- KEYTRUDA (Biological) $335.93
- NINLARO (Drug) $215.96
- VENCLEXTA (Drug) $167.52
- LIBTAYO (Biological) $146.94
- Enhertu (Drug) $128.15
- Orserdu (Drug) $122.74
- PADCEV (Biological) $118.86
- PYLARIFY (Drug) $116.64
- ZEPZELCA (Drug) $112.65
- EPKINLY (Drug) $90.90
- REBLOZYL (Biological) $84.51
- ERLEADA (Drug) $83.06
- Trodelvy (Drug) $82.20
- IMBRUVICA (Drug) $73.40
- DARZALEX (Biological) $69.83
- Lenvima (Drug) $68.96
- RETEVMO (Drug) $68.53
- PIQRAY (Drug) $60.63
- COSELA (Drug) $57.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Athens
Amanda Pack, Np, NP
Family — Payments: $13,342
Family $13,342
Katelyn Gillespie, Np, NP
Family — Payments: $10,429
Family $10,429
Mona Olive, Fnp, FNP
Family — Payments: $9,229
Family $9,229
Mary Mongare, Fnp-C, FNP-C
Family — Payments: $8,110
Family $8,110
Christen Mccabe, Fnp, FNP
Family — Payments: $7,587
Family $7,587
Mrs. Amanda Stephens, Np, NP
Family — Payments: $6,720
Family $6,720